The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum-Reference-Cited by-同舟云学术

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum

Published:2010-03 Issue:3 Volume:116 Page:351-357
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Zivanovic Oliver,Sima Camelia S.,Iasonos Alexia,Hoskins William J.,Pingle Pavani R.,Leitao Mario M.M.,Sonoda Yukio,Abu-Rustum Nadeem R.,Barakat Richard R.,Chi Dennis S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference33 articles.

1. Gynecologic Oncology Group: intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006

2. Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

3. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer;Alberts;N. Engl. J. Med.,1996

4. Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial

5. Gynecologic Oncology Group: secondary surgical cytoreduction for advanced ovarian carcinoma;Rose;N. Engl. J. Med.,2004

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls;Supportive Care in Cancer;2024-01-22

2. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study;Gynecologic Oncology;2023-12

3. Zytoreduktive Chirurgie und hypertherme intraperitoneale Chemoperfusion beim Ovarialkarzinom;Die Chirurgie;2022-10-06

4. Aktuelle Aspekte zur operativen Therapie des primären Ovarialkarzinoms;Der Gynäkologe;2022-02-01

5. Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer;Journal of Gynecologic Oncology;2022